Back

Ten-year outcomes in patients with hypertension and primary hyperaldosteronism undergoing surgical adrenalectomy versus medical therapy: data from the multinational collaborative network TriNetX

1 September 2024 (14:00 - 14:50)
Organised by: Logo
Congress Presentation Part of: Secondary and resistant hypertension Secondary Hypertension ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Rafael Belo Nunes

Hospital Alemao Oswaldo Cruz, Sao Paulo (Brazil)

8 More presentations in this session

Presentation thumbnail
Prediction of outcome in malignant hypertension patients using machine learning: a report from the West Birmingham malignant hypertension registry
Doctor A. Argyris (Athens, GR)
Abstract Slides Video
Presentation thumbnail
The effect of spironolactone versus eplerenone on blood pressure targets in resistant hypertension patients.
Mrs L. Mishchenko (Kyiv, UA)
Abstract Slides Video
Presentation thumbnail
Cerebral damage after malignant hypertensive crisis: cerebral MRI follow-up data
Doctor J. Liegey (Bordeaux, FR)
Abstract Slides Video
Presentation thumbnail
Impaired systemic microvascular function in patients with resistant arterial hypertension and microalbuminuria: an observational study
Doctor E. Tibirica (Rio de Janeiro, BR)
Abstract Slides Video
Presentation thumbnail
Semaglutide for the treatment of resistant hypertension
Doctor C. Kennedy (Dublin, IE)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary and resistant hypertension

The Event

Event poster

ESC Congress 2024

1 September 2024 14:00 CET
You may be interested in
thumbnail
Congress Session
Late-Breaking Clinical Trials: hypertension
thumbnail
Congress Session
New insights into antihypertensive treatment
thumbnail
Congress Session
Late-Breaking Clinical Science: new treatments and biomarkers in hypertension

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources